Presentation Title: Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass and Physical Function in Older Patients Receiving Semaglutide for Weight Loss Date: April 30, 2025 Start time: 12:30 ...

Werewolf Therapeutics (HOWL) announced the appointment of Steven Bloom as Chief Business Officer. Bloom brings more than 35 years of experience ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in ...

In January 2025, Beacon Therapeutics Holdings Limited reported that the FDA has awarded Regenerative Medicine Advanced Therapy (RMAT) designation to laru-zova (laruparetigene zovaparvovec ...

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal ...

Plus Therapeutics shares are trading higher by ... The company says it aims to build awareness of the REYOBIQ name and logo, reinforcing its progress in developing targeted radiotherapeutics ...

Pliant Therapeutics suffered a major setback with ... With the cancellation of its BEACON-IPF trial, these salaries no longer make sense with the organization going forward unless they attempt ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /CNW/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Feldan ...

Ceva, Inc. , the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, will announce results for the first quarter ...